Aurinia Pharmaceuticals (AUPH) Ownership - Who Owns Aurinia Pharmaceuticals?

2,129 Followers

Aurinia Pharmaceuticals (AUPH) Ownership Overview

13.26% Insiders

4.59% Mutual Funds

18.96% Other Institutional Investors

7.33% ETFs

55.86% Public Companies and

Individual Investors

The ownership structure of Aurinia Pharmaceuticals (AUPH) stock is a mix of institutional, retail, and individual investors. Approximately 30.88% of the company’s stock is owned by Institutional Investors, 13.26% is owned by Insiders, and 55.86% is owned by Public Companies and Individual Investors.

The ownership structure of Aurinia Pharmaceuticals (AUPH) stock is a mix of institutional, retail, and individual investors. Approximately 23.55% of the company’s stock is owned by Institutional Investors, 13.26% is owned by Insiders, and 7.33% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value
Jun 02, 2026	Kevin Tang	xxxxxxxxxxxxx	$12455227
Aug 05, 2025	Kevin Tang	xxxxxxxxxxxxx	$13590000
Aug 05, 2025	Greg Keenan	xxxxxxxxxxxxx	$210000

Show More Insider Trading Activity >

Top Shareholders

# of Shares	Type	% Holding	Value
13,044,106	Insider	10.14%	204,401,141
5,369,828	Institution	4.18%	84,145,205
1,866,703	Institution	1.45%	29,251,236
1,744,866	Insider	1.36%	27,342,050
1,257,683	Institution	0.98%	19,707,893
1,244,015	Institution	0.97%	19,493,715
733,838	Institution	0.57%	11,499,241
710,464	Institution	0.55%	11,132,971
662,900	Insider	0.52%	10,387,643
621,402	Insider	0.48%	9,737,369

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
1,866,703	Institution	1.45%	29,251,236
1,244,015	Institution	0.97%	19,493,715
710,464	Institution	0.55%	11,132,971
422,016	Institution	0.33%	6,612,991
336,741	Institution	0.26%	5,276,731
111,924	Institution	0.09%	1,753,849
92,212	Institution	0.07%	1,444,962
86,232	Institution	0.07%	1,351,255
84,000	Institution	0.07%	1,316,280
80,526	Institution	0.06%	1,261,842

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
iShares Russell 2000 ETF	2,856,828	Institution	2.22%	44,766,495
iShares Russell 2000 Growth ETF	977,962	Institution	0.76%	15,324,665
iShares Biotechnology ETF	849,560	Institution	0.66%	13,312,605
Vanguard Russell 2000 ETF	603,296	Institution	0.47%	9,281,709
Janus Henderson Small/Mid Cap Growth Alpha ETF	542,952	Institution	0.42%	8,312,595
Vanguard Health Care ETF	335,388	Institution	0.26%	4,970,450
Fidelity Enhanced Small Cap ETF	313,364	Institution	0.24%	4,797,603
Avantis U.S Small Cap Equity ETF	241,157	Institution	0.19%	3,711,406
Janus Henderson Small Cap Growth Alpha ETF	190,886	Institution	0.15%	2,922,465
Principal U.S. Small-Cap Multi-Factor ETF	120,768	Institution	0.09%	1,848,958

FAQ

Who Owns Aurinia Pharmaceuticals (AUPH)?

According to the latest TipRanks data, approximately 18.96% of the company's stock is held by institutional investors, 13.26% is held by insiders, and 55.86% is held by retail investors.

What percentage of Aurinia Pharmaceuticals (AUPH) stock is held by institutional investors?

According to the latest TipRanks data, approximately 18.96% of Aurinia Pharmaceuticals (AUPH) stock is held by institutional investors.

What percentage of Aurinia Pharmaceuticals (AUPH) stock is held by retail investors?

According to the latest TipRanks data, approximately 55.86% of Aurinia Pharmaceuticals (AUPH) stock is held by retail investors.

Who owns the most shares of Aurinia Pharmaceuticals (AUPH)?

Kevin Tang owns the most shares of Aurinia Pharmaceuticals (AUPH).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.